F15.282
BillableOther stimulant dependence with stimulant-induced sleep disorder
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is F15.282 an HCC code?
Yes. F15.282 maps to Drug Use Disorder/Substance Use Disorder, Moderate/Severe under the CMS-HCC V28 risk adjustment model (and Drug/Alcohol Dependence under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for F15.282
For F15.282 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed F15.282 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
F15.282 is the ICD-10-CM diagnosis code for other stimulant dependence with stimulant-induced sleep disorder. A person dependent on stimulant drugs who is experiencing sleep disturbances or insomnia caused by their stimulant use. F15.282 sits in the ICD-10-CM chapter for mental, behavioral and neurodevelopmental disorders (f01-f99), within the section covering mental and behavioral disorders due to psychoactive substance use (f10-f19).
Under the CMS-HCC V28 risk adjustment model, F15.282 maps to Drug Use Disorder/Substance Use Disorder, Moderate/Severe (HCC 137) with a community, non-dual, aged base RAF weight of 0.358. Under the older CMS-HCC V24 model, F15.282 maps to Drug/Alcohol Dependence (HCC 55) with a community, non-dual, aged base RAF weight of 0.334. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Document the specific sleep disorder (insomnia, hypersomnia, etc.) if known to provide clinical clarity. Because F15.282 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for F15.282 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Document the specific sleep disorder (insomnia, hypersomnia, etc.) if known to provide clinical clarity
- •Distinguish between stimulant-induced sleep disorder and primary sleep disorders unrelated to substance use
Clinical Significance
Stimulant dependence with stimulant-induced sleep disorder is extremely common, as stimulants directly disrupt sleep-wake regulation. Chronic dependence leads to severe insomnia during use and rebound hypersomnia during withdrawal or cessation attempts. This sleep disruption compounds the challenges of recovery and increases overall healthcare needs, making accurate documentation critical for risk adjustment.
Documentation Requirements
- ✓Documented stimulant dependence
- ✓Specific sleep disorder identified (insomnia, hypersomnia, circadian rhythm disruption)
- ✓Causal relationship between stimulant dependence and sleep disturbance
- ✓Impact on daily functioning and recovery efforts
- ✓Sleep assessment findings and any treatment interventions (pharmacologic or behavioral)
Commonly Confused Codes
- •F15.182 — Stimulant abuse with sleep disorder; requires abuse rather than dependence
- •F15.982 — Stimulant use, unspecified with sleep disorder; less specific regarding use pattern
- •G47.00 — Insomnia, unspecified; primary insomnia, not substance-induced
- •G47.10 — Hypersomnia, unspecified; primary hypersomnia, not substance-induced